中梁控股(02772.HK)兩筆優先票據交換要約屆滿
中梁控股(02772.HK)公布,有關於今年5月到期的8.5厘優先票據及7月到期的9.5厘優先票據的交換要約,已於倫敦時間上周五(10日)下午4時正屆滿,分別有897.5萬美元(佔5月票據的未償還本金總額2,762.8萬美元約32.49%)及5,859.2萬美元(佔7月票據的未償還本金總額7,116.6萬美元約82.33%)已提交作交換並獲接納。
經考慮公司於5月18日完成交換要約的結果及本次交換要約的結果,合資格持有人已將分別2.71億美元(佔5月票據的原始未償還本金額2.9億美元約93.56%)及4.27億美元(佔7月票據的原始未償還本金額4.4億美元約97.14%)有效提交作交換。
完成交換要約後,公司將發行本金總額2,258.84萬美元的額外於2023年4月到期的8.75厘優先票據,及本金總額4,497.86萬美元於2023年12月到期的9.75厘優先票據。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.